Between a bellicose North Korea, a missile strike in Syria, continued issues with ISIS in numerous countries and an overall spike in terror attacks around the world, some top strategists on Wall Street are…
A massive new Jefferies research report reminds investors that as a rule the first quarter is traditionally slower for biotechnology stocks.
These Permian-focused companies are trading well below their 52-week highs, and with all the potential catalysts in front of them they make solid buys now.
A very slow week by normal insider buying standards, and as we always like to remind our readers during earnings season, it is very likely to stay this way.
Analysts on Wall Street tend to have a herd mentality when it comes to long ideas, and sometimes bucking the herd mentality is tough. Yet, doing so can be highly profitable.
Insiders are using their last open windows to sell shares before they are closed for the earnings reports, and the volume dropped dramatically last week.
Here are six contrarian ideas from Credit Suisse for growth investors, with some of them being more contrarian than others.
A new JPMorgan research report makes the case that bank stocks are attractively valued now relative to the overall market, and the rest of 2017 looks bright.
Stocks are still trading close to all-time highs, and that means one thing for companies posting first-quarter results. Meet or beat expectations, and provide at least decent guidance, or sellers may show up in…
While Deutsche Bank does remain cautious on asset managers, it feels that brokers and the financial exchanges may be the best positioned against first-quarter expectations.
A corporate tax rate of 25% could provide some huge upside potential for companies with a large domestic exposure. These five top stocks make good sense for growth portfolios.
These five top homebuilders are in areas experiencing solid growth. With the potential for economic and job growth on the horizon, all these stocks could have a positive 2017 and way beyond.
Wednesday’s top analyst upgrades, downgrades and initiations included AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor and Wynn Resorts,
In a recent research note, the analysts at Merrill Lynch made a big move by adding a top software company to the firm's well respected US 1 list of stocks to buy
With inflation a real concern going forward, and the market expecting at least two more interest rate hikes, it makes sense to own stocks that should do well under those conditions.
Merrill Lynch has avoided high-flying momentum ideas and focused on solid companies that are reasonably priced and may stand to benefit from new initiatives from the administration and other macro events.
Jefferies analysts remain reasonably bullish, and in their top growth picks for the week the firm focuses on some stocks that could be top momentum stories for the second quarter.
For the past couple of months, Wall Street strategists and portfolio managers has been championing European stocks as better buys now than U.S. stocks.
Insiders have continued buying shares, especially at companies that either have traded off some or may have issues going forward.
A wild quarter with some huge insider selling as the market constantly hit all-time highs closed Friday with very light insider action last week.
